Reproductive Endocrinology,
Journal Year:
2023,
Volume and Issue:
70, P. 23 - 26
Published: Dec. 29, 2023
Research
objectives:
to
determine
the
activity
of
vascular
placental
growth
factors,
apoptosis
and
necrosis
neutrophils
in
blood
pregnant
women
with
post-COVID
syndrome.Methods
materials.
30
(the
main
group)
SARS-CoV-2,
positive
Ig
A,
M
or
G
SARS-CoV-2
at
30–34
weeks
pregnancy
took
part
study.
The
control
group
consisted
physiological
pregnancy.Blood
were
studied
by
flow
cytofluorometry.
proportion
that
stage
was
determined.
correlation
these
indicators
uncomplicated
course
gestational
process
during
development
complications
against
background
syndrome
determined.In
third
trimester
pregnancy,
we
collected
samples
effect
infection
on
angiogenesis.
We
evaluated
a
panel
biomarkers:
endothelial
factor
(VEGF),
PlGF,
interleukin-32α
(IL-32α).Results.
In
complicated
accompanied
syndrome,
level
24.30
±
0.50%
neutrophil
cells,
which
significantly
different
from
(4.45
0.25%)
(р
<
0.001).
late
apoptosis,
increased
4
times
–
4.20
0.65
16.80
0.54%
concentration
IL-32α
67.27
5.63
pg/ml.
Post-COVID
caused
an
increase
this
indicator
2.8
compared
(188.36
25.22
pg/ml)
(p
III
trimester,
VEGF
reached
maximum
values
192.20
10.02
pg/ml,
is
2
higher
than
same
time
(95.30
5.65
pg/ml),
PIGF
full-term
144.53
15.55
postpartum
decreased
43.92
4.81
only
30%
value
0.001).Conclusions.
metabolic
disorders
apoptotic
changes
tissue
are
confirmed
morphological
form
destructive
necrotic
microcirculatory
channel
placenta.
An
annexin-positive
activation
degree
fetoplacental
dysfunction,
violation
balance
factors
important
marker
for
predicting
fetal
retardation
syndrome.
iScience,
Journal Year:
2023,
Volume and Issue:
26(4), P. 106401 - 106401
Published: March 15, 2023
There
has
been
increasing
public
concern
that
COVID-19
vaccination
causes
menstrual
disturbance
regarding
the
relative
effect
of
compared
to
SARS-CoV-2
infection.
Our
objectives
were
test
potential
risk
factors
for
reporting
cycle
changes
following
and
compare
parameters
disease.
We
performed
a
secondary
analysis
retrospective
online
survey
conducted
in
UK
March
2021.
In
pre-menopausal
vaccinated
participants
(n
=
4,989),
18%
reported
after
their
first
vaccine
injection.
The
prevalence
any
was
higher
women
who
smoke,
have
history
disease,
or
are
not
using
estradiol-containing
contraceptives.
second
sample
including
both
unvaccinated
12,579),
alone
associated
with
abnormal
parameters,
while
disease
an
increased
heavier
bleeding,
"missed"
periods,
inter-menstrual
bleeding.
Obstetrics and Gynecology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 27, 2024
OBJECTIVE:
To
assess
whether
menstrual
cycle
timing
(follicular
or
luteal
phase)
of
coronavirus
disease
2019
(COVID-19)
vaccine
administration
is
associated
with
length
changes.
METHODS:
We
used
prospectively
collected
(2021–2022)
tracking
data
from
19,497
reproductive-aged
users
the
application
“Natural
Cycles.”
identified
was
delivered
in
follicular
phase
and
also
included
an
unvaccinated
control
group.
Our
primary
outcome
adjusted
within-individual
change
(in
days)
average
three
cycles
before
first
vaccination
(individuals
group
were
assigned
a
notional
date).
assessed
changes
second
clinically
significant
(8
days
more)
occurred
either
cycle.
RESULTS:
Most
individuals
younger
than
age
35
years
(80.1%)
North
America
(28.6%),
continental
Europe
(33.5%),
United
Kingdom
(31.7%).
In
vaccinated
group,
majority
received
mRNA
(63.8%
full
sample).
Individuals
experienced
1-day
longer
dose
COVID-19
compared
their
prevaccination
(first
dose:
1.00
day
[98.75%
CI,
0.88–1.13],
1.11
0.93–1.29]);
those
no
(respectively,
−0.09
−0.26
to
0.07],
0.06
−0.16
0.29],
0.08
−0.10
0.27],
0.17
−0.04
0.38]).
Those
during
more
likely
experience
more;
6.8%)
(3.3%
5.0%,
respectively;
P
<.001).
CONCLUSION:
vaccine–related
increases
are
receipt
half
phase).
Viruses,
Journal Year:
2024,
Volume and Issue:
16(7), P. 1142 - 1142
Published: July 16, 2024
The
COVID-19
pandemic
caused
by
SARS-CoV-2
has
presented
numerous
health
challenges,
including
long-term
COVID,
which
affects
female
reproductive
health.
This
review
consolidates
the
current
research
on
impact
of
menstrual
cycle,
ovarian
function,
fertility,
and
overall
gynecological
study
emphasizes
role
angiotensin-converting
enzyme
receptors
in
viral
entry
subsequent
tissue-specific
pathological
effects.
It
also
explores
potential
influence
long
COVID
hormonal
balance
immune
responses,
contributing
to
irregularities
impaired
function.
findings
indicate
a
higher
prevalence
among
women,
highlighting
substantial
implications
for
need
sex-sensitive
longitudinal
studies.
Enhanced
surveillance
targeted
are
essential
develop
effective
interventions
that
prioritize
women's
well-being
following
infection.
advocates
sex-informed
approach
ongoing
healthcare
strategies,
aiming
provide
up-to-date
pertinent
data
providers
general
public,
ultimately
improving
outcomes
females
affected
COVID.
Journal of Medical Internet Research,
Journal Year:
2023,
Volume and Issue:
26, P. e45139 - e45139
Published: Oct. 27, 2023
Emerging
digital
health
technology
has
moved
into
the
reproductive
market
for
female
individuals.
In
past,
mobile
apps
have
been
used
to
monitor
menstrual
cycle
using
manual
entry.
New
technological
trends
involve
use
of
wearable
devices
track
fertility
by
assessing
physiological
changes
such
as
temperature,
heart
rate,
and
respiratory
rate.
Obstetrics and Gynecology,
Journal Year:
2023,
Volume and Issue:
143(1), P. 83 - 91
Published: Aug. 10, 2023
To
assess
whether
coronavirus
disease
2019
(COVID-19)
is
associated
with
menstrual
cycle
length
changes
and,
if
so,
how
that
compares
those
undergoing
vaccination
or
no
event
(control).We
conducted
a
retrospective
cohort
analysis
in
which
we
analyzed
prospectively
tracked
cycle-length
data
from
users
of
period
tracker
application
who
also
responded
to
survey
regarding
COVID-19
symptoms
and
vaccination.
We
restricted
our
sample
aged
16-45
years,
normal
lengths
(24-38
days)
regular
tracking
behavior
during
the
five
cycles
around
similar
time
for
experiencing
(control
group).
calculated
within-user
change
(days)
three
consecutive
preevent
average
(either
vaccination,
disease,
neither;
1-3)
(cycle
4)
postevent
5)
cycles.
used
mixed-effects
models
estimate
age-
country-adjusted
difference
across
groups.We
included
6,514
110
countries
representing
32,570
(COVID-19
symptoms:
1,450;
vaccination:
4,643;
control:
421).
The
experienced
1.45-day
adjusted
increase
4
compared
their
(95%
CI
0.86-2.04).
vaccinated
group
1.14-day
vaccine)
0.60-1.69).
control
(neither
vaccine
nor
disease)
0.68-day
decrease
-1.18
-0.19)
period.
Post
hoc
tests
showed
significant
differences
magnitude
between
cohorts.
In
both
cohorts,
disappeared
cycle.Experiencing
small
These
resolve
quickly
within
next
cycle.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: May 22, 2024
SARS-CoV-2
is
the
causative
virus
of
devastating
COVID-19
pandemic
that
results
in
an
unparalleled
global
health
and
economic
crisis.
Despite
unprecedented
scientific
efforts
therapeutic
interventions,
fight
against
continues
as
rapid
emergence
different
variants
concern
increasing
challenge
long
COVID-19,
raising
a
vast
demand
to
understand
pathomechanisms
its
long-term
sequelae
develop
strategies
beyond
per
se
.
Notably,
addition
itself,
replication
cycle
clinical
severity
also
governed
by
host
factors.
In
this
review,
we
therefore
comprehensively
overview
pathogenesis
from
perspective
factors
host-virus
interactions.
We
sequentially
outline
pathological
implications
molecular
interactions
between
multi-organ
multi-system
summarize
current
agents
targeting
for
treating
these
diseases.
This
knowledge
would
be
key
identification
new
pathophysiological
aspects
mechanisms,
development
actionable
targets
tackling
sequelae.
Clinical Science,
Journal Year:
2024,
Volume and Issue:
138(4), P. 153 - 171
Published: Feb. 1, 2024
Abstract
The
impact
of
COVID-19
on
menstruation
has
received
a
high
level
public
and
media
interest.
Despite
this,
uncertainty
exists
about
the
advice
that
women
people
who
menstruate
should
receive
in
relation
to
expected
SARS-CoV-2
infection,
long
COVID
or
vaccination
menstruation.
Furthermore,
mechanisms
leading
these
reported
menstrual
changes
are
poorly
understood.
This
review
evaluates
published
literature
its
bleeding,
discussing
strengths
limitations
studies.
We
present
evidence
consistent
with
infection
having
an
association
bleeding
parameters
appears
less
significant.
An
overview
physiology
known
causes
abnormal
uterine
(AUB)
is
provided
before
potential
which
may
underpin
disturbance
COVID-19,
highlighting
areas
for
future
scientific
study.
Finally,
consideration
given
effect
have
including
ovarian
sex
hormones
acute
severity
susceptibility
variation
symptoms
across
cycle.
Understanding
current
addressing
gaps
our
knowledge
this
area
essential
inform
health
policy,
direct
treatment
facilitate
development
new
therapies,
reduce
improve
quality
life
those
experiencing
COVID.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(5), P. e0320162 - e0320162
Published: May 16, 2025
The
relationship
between
COVID-19
vaccines
and
menstrual
disturbance
is
unclear,
in
part
because
researchers
have
measured
different
outcomes
(e.g.,
delays
vs.
changes
to
cycle
length)
with
various
study
designs.
Menstrual
disruption
could
be
a
decisive
factor
people's
willingness
accept
the
vaccine.
We
searched
Medline,
Embase,
Web
of
Science
for
studies
investigating
length,
flow
volume,
post-menopausal
bleeding,
unexpected
or
intermenstrual
bleeding.
Data
were
analyzed
using
fixed-effects
meta-analysis
Shore's
adjusted
confidence
intervals
heterogeneity.
Seventeen
>1·9
million
participants
analyzed.
found
19%
greater
risk
increase
length
as
compared
unvaccinated
people
pre-vaccination
time-periods
(summary
relative
(sRR):
1·19;
95%
CI:
1·11-1·26;
n
=
23,718
participants).
was
same
Pfizer-BioNTech
(sRR:
1·15;
1·05-1·27;
16,595)
Moderna
1·05-1·25;
7,523),
similar
AstraZeneca
1·27;
1·02-1·59;
532),
higher
Janssen
1·69;
1·14-2·52;
751)
In
first
after
vaccination,
increased
by